Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 7846-7851

  Gundlach, Björn R ^a   Reiprich, Stefan ^a   Sopper, Sieghart ^b   Means, Robert E ^c   Dittmer, Ulf ^d   Mätz Rensing, Kerstin ^d   Stahl Hennig, Christiane ^d   Überla, Klaus ^a,e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Institut für Virologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENE STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINE PRODUCTION; VIRUS GENE;

EID: 0031707997     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.7846-7851.1998     Document Type: Article

References (42)

1. Almond, N., K. Kent, M. Cranage, E. Rud. B. Clarke, and E. J. Stott. 1995. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344.
2. Baier, M., A. Werner, N. Bannert, K. Metzner, and R, Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
3. Blatt, S. P., W. F. McCarthy, B. Bucko Krasnicka, G, P. Melcher, R. N. Boswell, J. Dolan, T. M. Freeman, J. M. Rusnak, R. E. Hensley, W. W. Ward, D. Barnes, and C. W. Hendrix. 1995. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J. Infect. Dis. 171:837-844.
4. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-832.
5. Bogers, W. M., H. Niphuis, P. ten Haaft, J. D. Laman, W. Koornstra, and J. L. Heeney. 1995. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 9:13-18.
6. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, and M. Murphey-Corb. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
7. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
8. Cole, K. S., J. L. Rowles, B. A. Jagerski, M. Murphey-Corb, T. Unangst, J. E. Clements, J. Robinson, M. S. Wyand, R. C. Desrosiers, and R. C. Montelaro. 1997. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71:5069-5079.
9. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. Dolan, M. J., M. Clerici, S. P. Blatt, C. W. Hendrix, G. P. Melcher, R. N. Boswell, T. M. Freeman, W. Ward, R. Hensley, and G. M. Shearer. 1995. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 172:79-87.
12. Dunn, C. S., B. Hurtel, C. Beyer, L. Gloecker, T. N. Ledger, C. Moog, M. P. Kieny, M. Methali, D. Schmitt, J. P. Gut, A. Kirn, and A. M. Aubertin. 1997. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res. Hum. Retroviruses 13:913-922.
13. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G proteincoupled receptor. Science 272:872-877.
14. Giavedoni, L., S. Ahmad, L. Jones, and T. Yilma. 1997. Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J. Virol. 71: 866-872.
15. Gundlach, B. R., H. Linhart, U. Dittmer, S. Sopper, S. Reiprich, D. Fuchs, B. Fleckenstein, G. Hunsmann, C. Stahl-Hennig, and K. Überla. 1997. Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin 2. J. Virol. 71:2225-2232.
16. Hoch, J., S. M. Lang, M. Weeger, C. Stahl Hennig, C. Coulibaly, U. Dittmer, G. Hunsmann, D. Fuchs, J. Müller, S. Sopper, B. Fleckenstein, and K. Überla. 1995. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69:4807-4813.
17. Johnson, V., and R. E. Byington. 1990. Quantitative assays for virus infectivity, p. 71-76. In A. Aldovini and B. D. Walker (ed.). Techniques in HIV research. Stockton Press, New York, N. Y.
18. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
19. Kneitz, C., T. Kerkau, J. Müller, C. Coulibaly, C. Stahl-Hennig, G. Hunsmann, T. Hünig, and A. Schimpl. 1993. Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques. Vet. lmmunol. Immunopathol. 36:239-255.
20. Lang, S. M., M. Weeger, C. Stahl Hennig, C. Coulibaly, G. Hunsmann, J. Müller, H. K. Müller-Hermelink, D. Fuchs, H. Wächter, M. M. Daniel, R. C. Desrosiers, and B. Fleckenstein. 1993. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67:902-912.
21. Letvin, N. L., J. Li, M. Halloran, M. P. Cranage, E. W. Rud, and J. Sodroski. 1995. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69:4569-4571.
22. Levy, J. A., C. E. Mackewitz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells, Immunol. Today 17:217-223.
23. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
24. Means, R. E., T. Greenough, and R. C. Desrosiers. 1997. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J. Virol. 71:7895-7902.
25. Miller, C. J., M. B. McChesney, X. Lu, P. J. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian-human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911-1921.
26. Morphey-Corb, M., L. N. Martin, B. Davison-Fairburn, R. C. Montelaro, M. Miller, M. West, S. Ohkawa, G. Baskin, J. Zhang, S. D. Putney, A. C. Allison, and D. A. Eppstein. 1989. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293-1297.
27. Norley, S., B. Beer, D. Binninger-Schinzel, C. Cosma, and R. Kurth. 1996. Protection from pathogenic SIVmac challenge following short-term infection with a Nef-deficient attenuated virus. Virology 219:195-205.
28. Norley, S. G., J. Lower, and R. Kurth. 1993. Insufficient inactivation of HIV-1 in human cryo poor plasma by beta-propiolactone: results from a highly accurate virus detection method. Biologicals 21:251-258.
29. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J. Heard, I. Clark-Lewis, D. F. Legier, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection hy T-cell-line-adapted HIV-1. Nature 382:833-835.
30. Petry, H., U. Dittmer, C. Stahl Hennig, C. Coulibaly, B. Makoschey, D. Fuchs, H. Wachter, T. Tolle, C. Morys Wortmann, F. J. Kaup, E. Jurkiewitz, W. Lüke, and G. Hunsmann. 1995. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J. Virol. 69:1564-1574.
31. sm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res. Hum. Retroviruses 12:993-999.
32. Reiprich, S., B. R. Gundlach, B. Fleckenstein, and K. Überla. 1997. Replication-competent chimeric lenti-oncovirus with expanded host cell tropism. J. Virol. 71:3328-3331.
33. Reiprich, S., et al. Unpublished data.
34. Shibata, R., C. Siemon, S. C. Czajak, R. C. Desrosiers, and M. A. Martin. 1997. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:8141-8148.
35. Sommerfell, M. A., and R. A. Weiss. 1990. Receptor interference groups of 20 retroviruses plating on human cells. Virology 176:58-69.
36. Soneoka. Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids. Res. 23:628-633.
37. Stahl-Hennig, C., O. Herchenroder, S. Nick, M. Evers, M. Stille-Siegener, K. D. Jentsch, F. Kirchhoff, T. Tolle, T. J. Gatesman, W. Lüke, and G. Hunsmann. 1990. Experimental infection of macaques with HIV-2ben, a novel HIV-2 isolate. AIDS 4:611-617.
38. Stahl-Hennig, C., G. Voss, S. Nick, H. Petry, D. Fuchs, H. Wachter, C. Coulibaly, W. Lüke, and G. Hunsmann. 1992. Immunization with Tween-ethertreated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology 186:588-596.
39. Überla, K., C. Stahl Hennig, D. Böttiger, K. Mätz-Rensing, F. J. Kaup, J. Li, W. A. Haseltine, B. Fleckenstein, G. Hunsmann, B. Öberg, and J. Sodroski. 1995. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA 92:8210-8214.
40. Volsky, D. J., M. Simm, M. Shahabuddin, G. Li, W. Chao, and M. J. Potash. 1996. Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J. Virol. 70: 3823-3833.
41. Weiss, R. A., and C. S. Tailor. 1995. Retrovirus receptors. Cell 82:531-533.
42. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Monteflori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.